An Open Clinical Study on Triphala Rasayana Evaluating Its Effect on Shonita Abhishyanda (Hyperlipidemia)

Shonita abhishyanda is characterized by the presence of excessive Kapha and Medas in the Rasa-Rakta dhatu, similar to Hyperlipedemia, which is characterized by excess lipoproteins travelling in the blood streams. Objectives-To evaluate the effect of Triphala Rasayana in reducing the levels of serum lipids in patients suffering from Shonita abhishyanda / Hyperlipidemia. Methodology: An open labelled clinical study with pre and post-test design. A minimum of 30 Patients presenting with Shonita abhishyanda / Hyperlipidemia were screened under strict diagnostic, inclusion and exclusion criteria. Such patients were included in the study after signing the informed consent. The primary and secondary outcome measures were assessed before and after the medication. Intervention: Dose: 6g (Aqueous extract of 24g of Triphala); Dosage Form: 12 (500 mg) capsules OD; Route of administration: Oral; Time of administration: Early Morning (2 hours) before breakfast; Anupana: Ushnodaka; Duration: 30 days. Results: Triphala Rasayana proved to be effective in reducing the Shonita abhishyanda by lowering the levels of Triglycerides, Total cholesterol, VLDL and increasing the level of HDL and improving the quality of life using SF Health Survey Score. All these changes were statistically significant with p=<0.001. Conclusion: Therefore we can conclude that Triphala Rasayana is proven to have lipid lowering effect in the management of Shonita abhishyanda and also improves the quality of life.